Varex Imaging (NASDAQ:VREX) had its target price upped by Jefferies Group LLC to $39.00 in a research note released on Friday morning. Jefferies Group LLC currently has a buy rating on the stock. Jefferies Group also issued estimates for Varex Imaging’s Q1 2018 earnings at $0.41 EPS, Q2 2018 earnings at $0.45 EPS, Q3 2018 earnings at $0.40 EPS, Q4 2018 earnings at $0.55 EPS and FY2022 earnings at $2.93 EPS.
Other equities analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Varex Imaging from a strong sell rating to a hold rating in a research note on Thursday, October 5th. J P Morgan Chase & Co raised shares of Varex Imaging from an underweight rating to a neutral rating and set a $33.00 price target for the company in a research note on Tuesday, August 8th.
Varex Imaging (NASDAQ:VREX) traded up $0.47 during mid-day trading on Friday, hitting $34.67. 696,900 shares of the stock traded hands, compared to its average volume of 437,834. Varex Imaging has a 12-month low of $25.00 and a 12-month high of $36.58. The company has a quick ratio of 1.63, a current ratio of 3.30 and a debt-to-equity ratio of 1.33.
Varex Imaging (NASDAQ:VREX) last released its quarterly earnings results on Thursday, November 9th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The business had revenue of $216.00 million for the quarter, compared to the consensus estimate of $213.73 million. The firm’s quarterly revenue was up 25.5% compared to the same quarter last year. research analysts predict that Varex Imaging will post 1.9 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Varex Imaging (VREX) Given New $39.00 Price Target at Jefferies Group LLC” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2017/11/12/varex-imaging-vrex-given-new-39-00-price-target-at-jefferies-group-llc.html.
Several institutional investors and hedge funds have recently bought and sold shares of VREX. BlackRock Inc. acquired a new stake in shares of Varex Imaging during the second quarter worth $156,842,000. Vanguard Group Inc. acquired a new stake in shares of Varex Imaging during the second quarter worth $116,560,000. QV Investors Inc. acquired a new stake in shares of Varex Imaging during the second quarter worth $59,839,000. First Eagle Investment Management LLC acquired a new stake in shares of Varex Imaging during the second quarter worth $59,452,000. Finally, Alecta Pensionsforsakring Omsesidigt acquired a new stake in shares of Varex Imaging during the third quarter worth $50,596,000. Institutional investors own 92.20% of the company’s stock.
About Varex Imaging
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.